Related Experiment Videos
Endocrine evaluation of infertile men
Urology
|December 31, 1997
Summary
Endocrine abnormalities are uncommon in male infertility, with most cases not significantly impacting management. Limited screening with testosterone and follicle-stimulating hormone (FSH) effectively identifies significant endocrinopathies.
Area of Science:
- Reproductive Endocrinology
- Male Infertility Diagnostics
Background:
- Endocrinologic abnormalities are a potential factor in male infertility.
- Determining the most effective screening methods is crucial for efficient diagnosis.
Purpose of the Study:
- To ascertain the frequency and nature of endocrine issues in men evaluated for infertility.
- To identify the optimal endocrine testing strategies for detecting these abnormalities.
Main Methods:
- Retrospective analysis of 1035 male patients across two infertility centers.
- Comparison of endocrine test results with clinical data to refine screening protocols.
Main Results:
- Abnormal endocrine studies were found in 9.6% of patients, mostly isolated elevated follicle-stimulating hormone (FSH).
- Only 1.7% had clinically significant endocrinopathies affecting management.
- Testing serum testosterone and FSH alone was as effective as a comprehensive hormonal panel.
- Limiting screening to men with sperm counts <10 million/mL identified nearly all significant cases.
Conclusions:
- Endocrinopathies are infrequent causes of male infertility.
- Targeted endocrine screening using serum testosterone and FSH in men with low sperm counts (<10 million/mL) is highly effective for identifying significant conditions.